1. Home
  2. STRO vs FVR Comparison

STRO vs FVR Comparison

Compare STRO & FVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STRO
  • FVR
  • Stock Information
  • Founded
  • STRO 2003
  • FVR 2016
  • Country
  • STRO United States
  • FVR United States
  • Employees
  • STRO N/A
  • FVR N/A
  • Industry
  • STRO Biotechnology: Biological Products (No Diagnostic Substances)
  • FVR
  • Sector
  • STRO Health Care
  • FVR
  • Exchange
  • STRO Nasdaq
  • FVR NYSE
  • Market Cap
  • STRO 172.8M
  • FVR 288.4M
  • IPO Year
  • STRO 2018
  • FVR 2024
  • Fundamental
  • Price
  • STRO $1.79
  • FVR $16.02
  • Analyst Decision
  • STRO Strong Buy
  • FVR Strong Buy
  • Analyst Count
  • STRO 7
  • FVR 5
  • Target Price
  • STRO $12.14
  • FVR $21.80
  • AVG Volume (30 Days)
  • STRO 1.2M
  • FVR 397.4K
  • Earning Date
  • STRO 11-13-2024
  • FVR 02-15-2025
  • Dividend Yield
  • STRO N/A
  • FVR 1.35%
  • EPS Growth
  • STRO N/A
  • FVR N/A
  • EPS
  • STRO N/A
  • FVR N/A
  • Revenue
  • STRO $160,955,000.00
  • FVR $58,655,152.00
  • Revenue This Year
  • STRO N/A
  • FVR N/A
  • Revenue Next Year
  • STRO N/A
  • FVR $18.00
  • P/E Ratio
  • STRO N/A
  • FVR N/A
  • Revenue Growth
  • STRO 230.90
  • FVR N/A
  • 52 Week Low
  • STRO $1.70
  • FVR $15.32
  • 52 Week High
  • STRO $6.13
  • FVR $19.76
  • Technical
  • Relative Strength Index (RSI)
  • STRO 31.80
  • FVR N/A
  • Support Level
  • STRO $1.80
  • FVR N/A
  • Resistance Level
  • STRO $2.15
  • FVR N/A
  • Average True Range (ATR)
  • STRO 0.13
  • FVR 0.00
  • MACD
  • STRO 0.04
  • FVR 0.00
  • Stochastic Oscillator
  • STRO 18.03
  • FVR 0.00

About STRO Sutro Biopharma Inc.

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.

About FVR FRONTVIEW REIT INC

FrontView REIT Inc is an internally managed net-lease REIT that is experienced in acquiring, owning, and managing out parcel properties that are net-leased to a diversified group of tenants. Its tenants include service-oriented businesses, such as restaurants, cellular stores, financial institutions, automotive stores and dealers, medical and dental providers, pharmacies, convenience and gas stores, car washes, home improvement stores, grocery stores, professional services as well as general retail tenants.

Share on Social Networks: